Nav1.7-IN-3 |
Catalog No.GC65320 |
Nav1.7-IN-3 est un inhibiteur sélectif de Nav1.7 du canal sodique voltage-dépendant biodisponible par voie orale avec une IC50 de 8 nM.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1788872-06-9
Sample solution is provided at 25 µL, 10mM.
Nav1.7-IN-3 is a selective, orally bioavailable voltage-gated sodium channel Nav1.7 inhibitor with an IC50 of 8 nM. Pain relief. Limited CNS penetration[1].
Nav1.7-IN-3 (compound 5) shows excellent potency, selectivity, behavioral efficacy in a rodent pain model (30 mg/kg, oral, 35 minutes), and efficacy in a mouse itch model (30 mg/kg, oral, 30 minutes)[1].
[1]. Roecker AJ, et al. Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice. Bioorg Med Chem Lett. 2017 May 15;27(10):2087-2093.
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *